Skip to main content

Table 9 Agreement and disparity among adverse pregnancy outcomes in four definitions of metabolic syndrome in pregnant women

From: Prevalence of metabolic syndrome in non-diabetic, pregnant Angolan women according to four diagnostic criteria and its effects on adverse perinatal outcomes

Definitions

Concordance

Diagnostic accuracy (%)

k-value (95 % CI)

p value

Agreement

Sensitivity

Specificity

PPV

NPV

Bartha vs NCEP ATP III

0.1739 (0.0214–0.3264)

<0.0001

Slight

100

71.4

13.3

100

NCEP ATP III vs Bartha

0.1739 (0.0214–0.3264)

<0.0001

Slight

13.3

100

100

71.4

Bartha vs Chatzi

0.3798 (0.1095–0.6502)

0.0009

Considerable

100

87.9

26.7

100

Chatzi vs Bartha

0.3798 (0.1095–0.6502)

0.0009

Considerable

26.7

100

100

87.9

Bartha vs JIS

0.1344 (0.0121–0.2567)

<0.0001

Slight

11.1

100

100

64.8

JIS vs Bartha

0.1344 (0.0121–0.2567)

<0.0001

Slight

100

64.8

11.1

100

NCEP ATP III vs Chatzi

0.5215 (0.3364–0.7065)

0.0003

Moderate

93.3

80

46.7

98.5

Chatzi vs NCEP ATP III

0.5215 (0.3364–0.7065)

0.0003

Moderate

46.7

98.5

93.3

80

NECP ATP III vs JIS

0.8613 (0.7549–0.9677)

0.0143

Excellent

83.3

100

100

90.8

JIS vs NECP ATP III

0.8613 (0.7549–0.9677)

0.0143

Excellent

100

90.8

83.3

100

Chatzi vs JIS

0.4701 (0.3005–0.6397)

<0.0001

Moderate

100

73.7

41.7

100

JIS vs Chatzi

0.4701 (0.3005–0.6397)

<0.0001

Moderate

41.7

100

100

73.7